Welcome address by Roche Diagnostics
Dr. Thomas Schinecker, CEO, Roche Diagnostics
Life after COVID: disease management and diagnostics in the post-pandemic era
Prof. Teo Yik Ying, Dean, Saw Swee Hock School of Public Health, National University of Singapore, Singapore
Mr. Anand K, CEO, SRL Diagnostics, India
Mr. Anand Swaminathan, Senior Partner – Leader of McKinsey Digital (Asia), McKinsey & Company, Singapore
Dr. Chris Douglas, Medical Director, Histopath Diagnostic Specialists, Australia
Dr. Harish Pillai, CEO, Metro Pacific Hospital Holdings, Philippines
For the past two years, healthcare systems everywhere were preoccupied with COVID-19 management, but as we gradually recalibrate to a new normal, questions arise about what the future will hold. What is the role of hospitals and clinical labs in a world where COVID-19 is endemic? How will we simultaneously meet the growing challenges of both infectious and chronic diseases? And what is the role of digital technology and new remote models of care in the post-COVID world?
Track 1 – Strengthening the core
Case study from India: Managing Lab Challenges in times of Pandemic
Ms. Ameera Shah, Promoter & Managing Director, Metropolis Healthcare Ltd, India
The coronavirus pandemic hit India in March 2020 resulting in a spontaneous reaction and action from Metropolis. The Indian government requested medical laboratories to submit applications for COVID-19 testing certification. Metropolis submitted our proposal knowing fully well that private labs that decided to rest for the novel virus would face a host of uncertainties – the government would almost certainly regulate the test and cap the price. Moreover, deciding to develop the test would have implications for the customers and might affect employee safety and morale. Nevertheless, we jumped in deep waters to help the country and the community. In this presentation, the presenter will share the challenges and learnings resulted from the pandemic; the series of decisions made by the Metropolis management and leadership team which they will definitely live to respect.
Track 2 – Expanding the core
Post-COVID-19 Policies and Impact
Dr. Khor Swee Kheng, Independent Health Policies Specialist, Malaysia
The COVID-19 pandemic has demonstrated the enduring importance of laboratory services. Lab services are integrated with health systems (like financing, workforce and healthcare delivery), and must compete for resources with other services (like clinical care, imaging and logistics). However, this competition are not necessarily zero-sum. Increasing investment in lab services can align with national resource allocation frameworks like five-year national strategic plans, while being conscious of the political, economic, legal and security determinants. Three specific policy angles for lab leaders are the regulatory approval and manufacturing aspects, the sustainable financing of innovative diagnostics and population-wide diagnostics, and integration with data systems.
Drawing patient closer to labs – The journey of a breast cancer survivor, member & volunteer of Breast Cancer Foundation
Ms. Noren Suseno, Patient Advocate, Breast Cancer Foundation, Singapore
Breast cancer is a life-changing event; one you cannot anticipate or plan for and one in which you have no choice. How we deal with living with it differs from one person to another—Hear from Ms. Noren Suseno, a member of Breast Cancer Foundation, as she shares her breast cancer journey.
Track 1 – Strengthening the core
Challenges in “New Normal”: Medical Laboratory Management
Col. Pitipat Jamnarnwej M.D, Head of Division of Clinical Microscopy and Hematology, Clinical Pathologist, Department of Clinical Pathology, Phramongkutklao Hospital and College of Medicine, Thailand
The COVID-19 pandemic has impacted medical laboratories all over the world. The laboratories are facing the challenges of delivering good quality lab services and keeping the patient and personnel safe from COVID-19. Many policies and technologies have been implemented in our lab to ensure the safety of our staff and help our Medical Technologists work more efficiently. This presentation will focus on sharing insights on our “New Normal” practices in times of COVID-19 pandemic.
Track 2 – Expanding the core
Picking Up the Pieces after COVID-19 Tsunami: Building-back-better Health System in India
Dr. Indu Bhushan, Senior Associate, School of Public Health, Johns Hopkins University, India
Under the current shadow of COVID-19 pandemic, the Presentation focuses on future directions India should take to build-back-better. It highlights the fault lines in the health sector that emerged during the pandemic and analyses the gaps that need to be urgently filled. The presenter will discuss the short and medium-term priorities in the health sector and how India can turn the COVID-19 crisis into an opportunity for ushering in long awaited reforms.
Drawing patient closer to labs – Enabling patients’ access to healthcare by GIVE.asia
Mr. Dennis Yeo, Director (Chief of Kindness), GIVE.asia, Singapore
Mr. Pong Yu Ming, Co-Founder & COO, GIVE.asia, Singapore
Join Co-Founder and COO, Pong Yu Ming and Chief of Kindness Dennis Yeo as they share more about the journey a patient goes through in order to gain access to medical treatment, which can be expensive. Yu Ming and Dennis run GIVE.asia, a fundraising platform that aims to support those who have fallen through the cracks and need support in affording urgent medical care.
Virtual Reference Site Visit: Taipei Veterans General Hospital – Impact of
Innovation on Patients and Society
Prof. Chou Teh Ying, Chief, Pathology and Laboratory Medicine Department, Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital (VGH-TPE) is a national first-class medical center in Taiwan with the ambition to impact the healthcare industry by leveraging innovation. This session will focus on how VGH-TPE: (i) introduces new technology solutions to improve patient experience, (ii) changes the way of disease management for better patient outcome, and (iii) embrace new ways of working to prioritize resources ensuring timely care for all patient groups amidst the COVID-19 pandemic.
End of day 1
VENTURING IN SPACE
Welcome address by Roche Diagnostics Asia Pacific
Ms. Wendy Bao, Chapter Lead, Innovation & Strategy, Roche Diagnostics Asia Pacific
Track 1 – Breaking boundaries
Leading Innovation as Future-Proof Hospital
Adj. Prof. Hananiel Widjaya, CEO, National Hospital, IndonesiaThought leaders in the healthcare community are facing a predicament during these times of pandemic. As technology disruption is shaping many industries, the same applies to hospitals. Implementation of electronic health record, IoT in medical devices, and Telemedicine are mostly pioneered by start-up apps, which are partially developed and are not seamless with offline business models. Meanwhile, hospitals still adopt a conservative approach to business management. The reason for this is not that they cannot read the trends, but due to lack of capabilities to influence and drive change in the organizations. This session will focus on experience sharing of the challenges and importance of developing a strategy to evolve during this pandemic era.
Track 2 – Exploring beyond
Shaping a healthcare ecosystem
Mr. Dirk Dumortier, Head of Business Development Smart-City and Healthcare (APAC), Alcatel-Lucent Enterprise, Singapore
Ecosystems have been around for ages. They were built to cement relationships for existing players in a given industry and most of the time-limited to adjacent partnerships. The pandemic has highlighted the urgent need to expand healthcare infrastructure beyond the hospital walls, to better reach remote communities, and to enable 24-hour services to patients, no matter where they are. This requires reengineering our existing concept of healthcare ecosystem to one that supports a connected healthcare model, fostering partnerships with non-traditional players, and rethinking the definition of how we can best deliver healthcare services. In this session, we will highlight the healthcare ecosystem over the years. The impact of both digital transformation and COVID-19 and the changes this may bring on labs and healthcare professionals. Next, we will discuss the drivers and enablers of digital transformation so that you are prepared for the future.
Featured Startup: Fertility Care – Ava
Perks of the Pandemic – Patient Reflections
Ms. Jessica Bean, Chairperson (Patient Advocate), Patient Voice Initiative, Australia
The pandemic has been a particularly stressful, confusing, and challenging experience for people living with a chronic illness. However, rapid shifts in healthcare delivery have also offered some unanticipated benefits. As a cystic fibrosis and diabetes patient, Jessica Bean reflects on the rapid adoption of digital health technology, how it has had a positive impact on her health management and what she would like industry, healthcare providers and decision-makers to consider as we look to the future of digital health.
Featured Startup: Diabetes Care – Fitterfly
Virtual Home Monitoring Point-of-Care Testing in Country Practice
Ms. Rosy Tirimacco, Operations and Research Manager, The Integrated Cardiovascular Clinical Network Country Health South Australia, Australia
Innovative and collaborative models of care for chronic conditions are required to address the complex challenges and barriers associated with chronic disease management. Timely access to pathology results improves management of chronic disease patients, potentially preventing additional visits to the practice. Home monitoring for chronic disease patients has been shown to reduce hospital admissions and enable patients to have a more active role in the management of their disease. In partnership with Country SA Primary Health Network (CSAPHN), Integrated Cardiovascular Clinical Network South Australia (iCCnet SA) have implemented a coordinated care approach using virtual home monitoring and point of care testing within the general practitioner (GP) setting. The My Health Point of Care Innovative Technologies Trial (PoCiTT) program has been developed as a tool to provide extra resources to GP’s to manage their chronic disease patients in rural and remote locations. This allows for daily monitoring of patients’ health status, early identification of condition deterioration and early intervention. The goal is to reduce the demand on hospital services, improve patient outcomes and enable the GP to better provide services to ease the overall burden on increasingly scarce clinical resources.
Featured Startup: Diabetes Care – Gemii TechnologyGemii Technology is a private domain expert deeply engaged in the enterprise WeChat ecosystem, and boosts the digital upgrade of industrial services with artificial intelligence (AI) and software as a service (SaaS) products and operation services.gemii.cc
Track 1 – Breaking boundaries
Precision Public Health – What is it and Why Should Anybody Care?
A/Prof. Jeremy Lim, Director, Leadership Institute of Global Health Transformation (LIGHT), Saw Swee Hock School of Public Health, National University of Singapore, Singapore
Can Public health be personal? It sounds strange, perhaps almost oxymoronic that Public health which focuses on populations can at the same time be personalised. However, with the now widespread use of machine learning techniques in many facets of everyday life and the explosion in personal data, Public health can be precise and personal. In this discussion, Jeremy, founding president of the Precision Public Health Asia Society will share what precision public health is, its applications and what the future could look like.
Track 2 – Exploring beyond
Changing Insurance Landscape
Ms. Susan Fanning, Chief Health & Wellbeing Officer, Prudential Life Assurance Public Company Ltd., ThailandThe insurance industry is undergoing profound change. Asian countries are aging faster than the west. Metabolic obesity is common amongst Asians. COVID 19 has caused consumers to reassess the importance of their health, whilst accelerating the adoption of digitization and transformation of insurers. This has created a new world where insurers can help consumers to prevent, postpone and protect against the onset of diseases.
Closing Remarks by Roche Diagnostics Asia Pacific
Mr. Lance Little, Managing Director, Region Asia Pacific
End of event